Your browser doesn't support javascript.
loading
The efficacy advantage of evolocumab (AMG 145) dosed at 140mg every 2weeks versus 420mg every 4weeks in patients with hypercholesterolemia: Evidence from a meta-analysis.
He, Xiao-Xiao; Zhang, Rong; Zuo, Pei-Yuan; Liu, Yu-Wei; Zha, Xiang-Nan; Shan, Sheng-Shuai; Liu, Cheng-Yun.
Afiliação
  • He XX; Key Laboratory of Geriatrics of Health Ministry, Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhang R; Key Laboratory of Geriatrics of Health Ministry, Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zuo PY; Key Laboratory of Geriatrics of Health Ministry, Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Liu YW; Key Laboratory of Geriatrics of Health Ministry, Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zha XN; Key Laboratory of Geriatrics of Health Ministry, Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Shan SS; Key Laboratory of Geriatrics of Health Ministry, Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Liu CY; Key Laboratory of Geriatrics of Health Ministry, Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: lcyun2016@163.com.
Eur J Intern Med ; 38: 52-60, 2017 Mar.
Article em En | MEDLINE | ID: mdl-28341307
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Hipercolesterolemia / Anticorpos Monoclonais / Anticolesterolemiantes Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Eur J Intern Med Assunto da revista: MEDICINA INTERNA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Hipercolesterolemia / Anticorpos Monoclonais / Anticolesterolemiantes Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Eur J Intern Med Assunto da revista: MEDICINA INTERNA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China